July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Diabetic Vitrectomy: Evaluating the Impact of Lens Status in Recurrent Vitreous Hemorrhage
Author Affiliations & Notes
  • Jessica Alana Scott
    Ophthalmology, The Ohio State University, Columbus, Ohio, United States
  • William Bloom
    Ophthalmology, The Ohio State University, Columbus, Ohio, United States
  • Liyung T. Chou
    Ophthalmology, The Ohio State University, Columbus, Ohio, United States
  • Matthew Ohr
    Ophthalmology, The Ohio State University, Columbus, Ohio, United States
  • Footnotes
    Commercial Relationships   Jessica Scott, None; William Bloom, None; Liyung T. Chou, None; Matthew Ohr, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6543. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jessica Alana Scott, William Bloom, Liyung T. Chou, Matthew Ohr; Diabetic Vitrectomy: Evaluating the Impact of Lens Status in Recurrent Vitreous Hemorrhage. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6543.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Diabetic retinopathy is a leading cause of vision loss in developed countries. Post-vitrectomy vitreous hemorrhage is a major complication that often leads to visual impairment and need for reoperation. The management of diabetic vitrectomy in phakic patients has been debated in the retina community throughout the years. It is postulated that the presence of the crystalline lens anatomically limits access to the anterior vitreous and epiretinal proliferation during vitrectomy in advanced cases of proliferative diabetic vitrectomy. Therefore, vitreous hemorrhages may be more likely to persist or recur in these phakic patients. The purpose of this retrospective study was to evaluate the impact of the lens status, whether phakic or pseudophakic, in the rate of recurrence of non-clearing vitreous hemorrhage (NCVH) in diabetic patients undergoing pars plana vitrectomy.

Methods : This was a retrospective chart review of diabetic retinopathy patients who underwent primary pars plana vitrectomy by one surgeon for complications relating to diabetic retinopathy between June 1, 2015 and February 1, 2018. The institutional review boards of The Ohio State University (Columbus, OH) approved this study.

Results : During the study period, 105 eyes underwent primary pars plana vitrectomy for diabetic disease. Seventy eyes were phakic at the time of surgery. We found that 17% of phakic eyes required reoperation for recurrent vitreous hemorrhage in comparison to 5.7% in pseudophakic eyes (P < 0.0892). Of the phakic patient requiring reoperation for NCVH, the initial indication for surgery was traction retinal detachment + vitreous hemorrhage in 92% of cases. Overall, 90% of all eyes received intraoperative Bevacizumab injection at the end of each case.

Conclusions : The findings of this study suggest that there may be a greater need for reoperation for NCVH in the phakic diabetic patients. Although significance is limited by the sample size, this is promising data to aid vitreoretinal surgeons in the decision-making process of managing the crystalline lens in diabetic vitrectomy.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×